Open AccessForecast of demand for antiretroviral drugs in low and middle-income countries: 2007–2008
Author(s) -
Omar Galárraga,
Megan O’Brien,
Juan Pablo Gutiérrez,
Françoise Renaud-Théry,
Boniface Dongmo Nguimfack,
Michel Beusenberg,
Katherine Waldman,
Anil Soni,
Stefano Bertozzi,
Robert Greener
Publication year - 2007
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/01.aids.0000279712.32051.29
Subject(s) - nelfinavir , saquinavir , indinavir , lamivudine , nevirapine , didanosine , zidovudine , medicine , human immunodeficiency virus (hiv) , virology , viral load , antiretroviral therapy , viral disease , hepatitis b virus , virus
Middle and low-income countries have scaled up HIV treatment in the past 5 years. To maintain this effort, information regarding the amounts and types of drugs is needed. Shortages or overstock of active pharmaceutical ingredients make the scale-up efforts more difficult and costly. To inform global planning and implementation, we estimate the volume of current and future demand for active pharmaceutical ingredients for first and second-line antiretroviral drugs.